OSA and cardiometabolic risk: What's the bottom line? - Wikidata - wikimedia - TriplyDB

OSA and cardiometabolic risk: What's the bottom line?

OSA and cardiometabolic risk: What's the bottom line?

http://www.wikidata.org/entity/Q39120083

about

OSA and cardiometabolic risk: What's the bottom line?

http://www.wikidata.org/entity/Q39120083

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

OSA and cardiometabolic risk: What's the bottom line?

@en

OSA and cardiometabolic risk: What's the bottom line?

@nl

type

label

OSA and cardiometabolic risk: What's the bottom line?

@en

OSA and cardiometabolic risk: What's the bottom line?

@nl

prefLabel

OSA and cardiometabolic risk: What's the bottom line?

@en

OSA and cardiometabolic risk: What's the bottom line?

@nl

P1433

Q39120083-09E7E6CC-F383-438F-A46A-EA13BD3A25F4

P1476

Q39120083-5AE3A76B-55E3-4385-BEB0-234E3683F428

P2093

Q39120083-2351A3E9-267B-4643-98E4-07624AD2B3A8

Q39120083-2BB99B80-9674-4179-8B19-AA2C95B8EABF

P2860

Q39120083-012D6331-EE7F-4300-8387-BAEEA84D2E5D

Q39120083-05DE4975-6374-492B-B32B-B87AF312E609

Q39120083-0674C572-00D7-4C72-ACBE-78A8902E6876

Q39120083-094C17E2-2911-4768-8765-E5A006463CEB

Q39120083-11CDF372-0D17-4B98-8BF7-85CE75E6F9C7

Q39120083-131E6D51-D101-4967-894E-EED9173EF857

Q39120083-14F688C9-1461-48A2-BA20-1ADFF9AF68E3

Q39120083-169BC8DE-617B-4B2B-98F2-AA41772CDFDF

Q39120083-178C97A4-1789-4938-873E-577A0E4B59E9

Q39120083-18823F38-02ED-4FA7-BAE1-943BB9609D77

P304

Q39120083-B45160A1-4412-495A-AD5B-083E0BAE6E06

P31

Q39120083-0E3B2F2A-A449-4858-9F21-A2871FC365E5

P356

Q39120083-12E33E53-4EFA-4833-95FC-5EBEAC74D20B

P433

Q39120083-4EDD1FE9-ACF6-45BE-AAA3-DC80CA8C6AD0

P478

Q39120083-E5296F11-443A-4535-B87F-7DB0D6D86C30

P50

Q39120083-A68BD463-3B02-4E31-B48F-732123979BA9

P577

Q39120083-7EB0FB37-1A46-43DA-9246-57FDBF1FE596

P698

Q39120083-C899FF1E-5536-4372-BBEE-7FCC8ACBCC4D

P356

P1433

P1476

OSA and cardiometabolic risk: What's the bottom line?

@en

P2093

Camilla M Hoyos

http://www.w3.org/2001/XMLSchema#string

Luciano F Drager

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous Positive Airway Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension: A Meta-Analysis of Randomized Controlled Trials

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Associations between Obstructive Sleep Apnea, Sleep Duration, and Abnormal Fasting Glucose. The Multi-Ethnic Study of Atherosclerosis

Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells

Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study

Adherence to continuous positive airway pressure therapy: the challenge to effective treatment

CPAP versus oxygen in obstructive sleep apnea

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial.

Sleep-disordered breathing and mortality: a prospective cohort study.

P304

420-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/RESP.12984

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28161892

http://www.w3.org/2001/XMLSchema#string